Á lódáil...
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome
PURPOSE: We evaluated the efficacy and safety of febuxostat, a non-purine xanthine oxidase inhibitor, used for prevention of hyperuricemia associated with tumor lysis syndrome (TLS). METHODS: Records of adult patients with newly diagnosed or relapsed hematologic malignancies who received febuxostat...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Springer International Publishing
2014
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4164671/ https://ncbi.nlm.nih.gov/pubmed/25279293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-501 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|